ES2040879T3 - Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina. - Google Patents

Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.

Info

Publication number
ES2040879T3
ES2040879T3 ES198888402242T ES88402242T ES2040879T3 ES 2040879 T3 ES2040879 T3 ES 2040879T3 ES 198888402242 T ES198888402242 T ES 198888402242T ES 88402242 T ES88402242 T ES 88402242T ES 2040879 T3 ES2040879 T3 ES 2040879T3
Authority
ES
Spain
Prior art keywords
piperidine derivatives
pirimidinylaminic
procedure
preparation
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888402242T
Other languages
English (en)
Inventor
Philippe Manoury
Alfred Saarmets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Application granted granted Critical
Publication of ES2040879T3 publication Critical patent/ES2040879T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS PIRIDINILAMIADOS DE PIPERIDINA QUE RESPONDEN A LA FORMULA(I) EN LA QUE X ES UN RADICAL (CH2)2, CH = CH O CH2 - CO, Y ES EL RADICAL CH = CH O UN ATOMO DE AZUFRE, N ES 2, 3 O 4, R1 ES UN ATOMO DE H O DE HALOGENO, R2 ES UN ATOMO DE H O UN RAQDICAL (C1 - 4)ALQUILO, R3 ES UN ATOMO DE H O EL RADICAL HIDROXI, ASI COMO SUS SALES DE ADICION A LOS ACIDOS FARMACEUTICAMENTE ACVEPTABLES. APLICACION EN TERAPEUTICA.
ES198888402242T 1987-09-09 1988-09-07 Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina. Expired - Lifetime ES2040879T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712502A FR2620121B1 (fr) 1987-09-09 1987-09-09 ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES2040879T3 true ES2040879T3 (es) 1993-11-01

Family

ID=9354744

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888402242T Expired - Lifetime ES2040879T3 (es) 1987-09-09 1988-09-07 Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.

Country Status (18)

Country Link
US (2) US4891376A (es)
EP (1) EP0307303B1 (es)
JP (1) JPH01104069A (es)
KR (1) KR890005086A (es)
AT (1) ATE70062T1 (es)
AU (1) AU603004B2 (es)
DE (1) DE3866646D1 (es)
DK (1) DK499088A (es)
ES (1) ES2040879T3 (es)
FI (1) FI884132A (es)
FR (1) FR2620121B1 (es)
GR (1) GR3003481T3 (es)
HU (1) HU199141B (es)
IL (1) IL87609A (es)
NO (1) NO883994L (es)
NZ (1) NZ226089A (es)
PT (1) PT88460B (es)
ZA (1) ZA886698B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618436B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
KR100351012B1 (ko) * 1994-04-20 2002-12-26 아지노모토 가부시키가이샤 피페리딘유도체및이를함유하는항혈소판제
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
JP2914324B2 (ja) * 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
US5869497A (en) * 1996-03-15 1999-02-09 Eli Lilly And Company Method of treating or ameliorating the symptoms of common cold or allergic rhinitis
US7941675B2 (en) * 2002-12-31 2011-05-10 Burr James B Adaptive power control
US7180322B1 (en) 2002-04-16 2007-02-20 Transmeta Corporation Closed loop feedback control of integrated circuits
US7953990B2 (en) * 2002-12-31 2011-05-31 Stewart Thomas E Adaptive power control based on post package characterization of integrated circuits
US7228242B2 (en) 2002-12-31 2007-06-05 Transmeta Corporation Adaptive power control based on pre package characterization of integrated circuits
US7949864B1 (en) * 2002-12-31 2011-05-24 Vjekoslav Svilan Balanced adaptive body bias control
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US7692477B1 (en) * 2003-12-23 2010-04-06 Tien-Min Chen Precise control component for a substrate potential regulation circuit
US7129771B1 (en) 2003-12-23 2006-10-31 Transmeta Corporation Servo loop for well bias voltage source
US7012461B1 (en) 2003-12-23 2006-03-14 Transmeta Corporation Stabilization component for a substrate potential regulation circuit
US7649402B1 (en) 2003-12-23 2010-01-19 Tien-Min Chen Feedback-controlled body-bias voltage source
US7774625B1 (en) 2004-06-22 2010-08-10 Eric Chien-Li Sheng Adaptive voltage control by accessing information stored within and specific to a microprocessor
EP2243778B1 (en) * 2008-01-30 2014-10-29 Nippon Zoki Pharmaceutical Co., Ltd. Piperidine derivative
JP5083989B2 (ja) * 2008-11-20 2012-11-28 日本臓器製薬株式会社 ピペリジン誘導体を含有する医薬
EP2727919B1 (en) * 2011-06-28 2019-05-08 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Benzocycloheptanethiophene derivatives for anti-allergic reactions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives

Also Published As

Publication number Publication date
US4891376A (en) 1990-01-02
IL87609A (en) 1992-09-06
FR2620121B1 (fr) 1990-01-05
ZA886698B (en) 1989-04-26
GR3003481T3 (en) 1993-02-17
IL87609A0 (en) 1989-01-31
DK499088D0 (da) 1988-09-08
FI884132A (fi) 1989-03-10
DE3866646D1 (de) 1992-01-16
JPH01104069A (ja) 1989-04-21
FR2620121A1 (fr) 1989-03-10
US4929621A (en) 1990-05-29
AU2201088A (en) 1989-03-23
PT88460B (pt) 1992-11-30
PT88460A (pt) 1988-10-01
NZ226089A (en) 1990-06-26
ATE70062T1 (de) 1991-12-15
HU199141B (en) 1990-01-29
KR890005086A (ko) 1989-05-11
NO883994D0 (no) 1988-09-08
DK499088A (da) 1989-04-03
EP0307303B1 (fr) 1991-12-04
EP0307303A1 (fr) 1989-03-15
FI884132A0 (fi) 1988-09-08
NO883994L (no) 1989-03-10
HUT47927A (en) 1989-04-28
AU603004B2 (en) 1990-11-01

Similar Documents

Publication Publication Date Title
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
DK132789A (da) 9-halogen-(z)-prostaglandinderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
ES539658A0 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
DK359387D0 (da) Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling
DK640687D0 (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
FR2618436B1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique
DE59206593D1 (de) Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe
SE7605899L (sv) Forfarande for framstellning av tienopyridinderivat
ES2037783T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas.
EP0367036A3 (en) Substituted 3-aminosydnonimines, process for their preparation and their use
ES8504193A1 (es) Un procedimiento de preparacion de hexahidro-indolo-naftiridinas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 307303

Country of ref document: ES